HEXO Corp (HEXO)
0.71
0.00 (0.00%)
USD |
NASDAQ |
Jun 30, 16:00
HEXO Gross Profit (Quarterly): -6.898M for April 30, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2023 | -6.898M |
| January 31, 2023 | -4.431M |
| October 31, 2022 | -13.04M |
| July 31, 2022 | -27.84M |
| April 30, 2022 | -4.161M |
| January 31, 2022 | -2.020M |
| October 31, 2021 | -25.42M |
| July 31, 2021 | 2.591M |
| April 30, 2021 | 6.998M |
| January 31, 2021 | 14.44M |
| October 31, 2020 | 13.77M |
| July 31, 2020 | -25.38M |
| April 30, 2020 | 4.170M |
| Date | Value |
|---|---|
| January 31, 2020 | -6.011M |
| October 31, 2019 | -15.82M |
| July 31, 2019 | -12.17M |
| April 30, 2019 | 16.39M |
| January 31, 2019 | 8.709M |
| October 31, 2018 | 5.552M |
| July 31, 2018 | 0.3978M |
| April 30, 2018 | 2.094M |
| January 31, 2018 | 0.5944M |
| October 31, 2017 | 1.969M |
| July 31, 2017 | 2.317M |
| April 30, 2017 | 1.035M |
| January 31, 2017 | 0.7042M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-27.84M
Minimum
Jul 2022
16.39M
Maximum
Apr 2019
-3.714M
Average
-4.161M
Median
Apr 2022
Gross Profit (Quarterly) Benchmarks
| Tilray Brands Inc | 67.16M |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 39.93M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.0804M |